Work

Phase II Trial of Subcutaneous Interferon Followed by Intravenous Hybrid Bolus/Continuous Infusion Interleukin-2 in the Treatment of Renal Cell Carcinoma: Final Results of Cancer Biotherapy Research Group 95-09

Year: 2006

Type: article

Study design: Clinical Trial

Source: Cancer Biotherapy and Radiopharmaceuticals

DOI: 10.1089/cbr.2006.21.130

Authors: Robert O. Dillman, Michael C. Wiemann, D. Fritz Tai, Carol B. DePriest, Gamini Soori, James J. Stark, Khosrow Mahdavi, Curtis K. Church

Institutions: Hoag Memorial Hospital Presbyterian, St Vincent Hospital, CHI Health Creighton University Medical Center - Bergan Mercy, Middle Tennessee State University

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2091298779

FWCI: 0.879

Cites: 26

Cited by: 8

Related to: 10